Description: This illustrated pamphlet titled "IF IT'S COVID, PAXLOVID" is a rare find for those interested in health topics related to COVID. It is authored by Pfizer and has been approved by the FDA, making it a trustworthy source of information. The format of this pamphlet is a chapbook and it is written in English. The book title clearly indicates its focus on COVID, and the illustrations make it an engaging read. This would make a great addition to any collection of health-related books or magazines. Don't miss the opportunity to own this rare and informative piece. Pfizer Inc. (/ˈfaɪzər/ FY-zər)[3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($37 billion in 2022 revenues), Nirmatrelvir/ritonavir ($18 billion in 2022 revenues), Apixaban ($6 billion in 2022 revenues), a pneumococcal conjugate vaccine ($6 billion in 2022 revenues), and Palbociclib ($5 billion in 2022 revenues).[1] In 2022, 42% of the company's revenues came from the United States, 8% came from Japan, and 50% came from other countries.Pfizer was a component of the Dow Jones Industrial Average stock market index from 2004 to August 2020.[4][5][6][7] The company ranks 38th on the Fortune 500[8] and 39th on the Forbes Global 2000.
Price: 10 USD
Location: Islip Terrace, New York
End Time: 2024-09-17T21:08:53.000Z
Shipping Cost: 4.63 USD
Product Images
Item Specifics
All returns accepted: ReturnsNotAccepted
Format: Chapbook/Pamphlet
Language: English
Book Title: IF IT'S COVID, PAXLOVID
Author: PFIZER
Features: Illustrated
Genre: HEALTH
Topic: COVID
